Literature DB >> 25212079

Diagnostic schemes for reducing epidemic size of African viral hemorrhagic fever outbreaks.

Iruka N Okeke1, Robert S Manning, Thomas Pfeiffer.   

Abstract

INTRODUCTION: Viral hemorrhagic fever (VHF) outbreaks, with high mortality rates, have often been amplified in African health institutions due to person-to-person transmission via infected body fluids.  By collating and analyzing epidemiological data from documented outbreaks, we observed that diagnostic delay contributes to epidemic size for Ebola and Marburg hemorrhagic fever outbreaks.
METHODOLOGY: We used a susceptible-exposed-infectious-removed (SEIR) model and data from the 1995 outbreak in Kikwit, Democratic Republic of Congo, to simulate Ebola hemorrhagic fever epidemics. Our model allows us to describe the dynamics for hospital staff separately from that for the general population, and to implement health worker-specific interventions.
RESULTS: The model illustrates that implementing World Health Organization/US Centers for Disease Control and Prevention guidelines of isolating patients who do not respond to antimalarial and antibacterial chemotherapy reduces total outbreak size, from a median of 236, by 90% or more. Routinely employing diagnostic testing in post-mortems of patients that died of refractory fevers reduces the median outbreak size by a further 60%. Even greater reductions in outbreak size were seen when all febrile patients were tested for endemic infections or when febrile health-care workers were tested.  The effect of testing strategies was not impaired by the 1-3 day delay that would occur if testing were performed by a reference laboratory.
CONCLUSION: In addition to improving the quality of care for common causes of febrile infections, increased and strategic use of laboratory diagnostics for fever could reduce the chance of hospital amplification of VHFs in resource-limited African health systems.

Entities:  

Mesh:

Year:  2014        PMID: 25212079     DOI: 10.3855/jidc.4636

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  3 in total

1.  Development and Evaluation of Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) Assay Coupled with a Portable Device for Rapid Diagnosis of Ebola Virus Disease in Guinea.

Authors:  Yohei Kurosaki; N'Faly Magassouba; Olamide K Oloniniyi; Mahamoud S Cherif; Saori Sakabe; Ayato Takada; Kenji Hirayama; Jiro Yasuda
Journal:  PLoS Negl Trop Dis       Date:  2016-02-22

2.  The post-Ebola virus disease scourge in Nigeria: Individual levels of preparedness among physicians in the Federal Capital Territory Abuja.

Authors:  Adewale L Alli; Maxwell M Nwegbu; Perpetua U Ibekwe; Titus S Ibekwe
Journal:  Ann Afr Med       Date:  2016 Oct-Dec

3.  A new matrix for scoring the functionality of national laboratory networks in Africa: introducing the LABNET scorecard.

Authors:  Pascale Ondoa; Tjeerd Datema; Mah-Sere Keita-Sow; Jean-Bosco Ndihokubwayo; Jocelyn Isadore; Linda Oskam; John Nkengasong; Kim Lewis
Journal:  Afr J Lab Med       Date:  2016-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.